Markets Irrationally React To Coronavirus, Creating Buying Opportunity For Zoetis [Seeking Alpha]
Zoetis Inc. Class A (ZTS)
Last zoetis inc. class a earnings: 2/13 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.zoetis.com
Company Research
Source: Seeking Alpha
Summary Zoetis released strong 2019 Q4 and Fiscal Year End earnings on February 13, 2020, beating analyst estimates. I adjusted my models after this recent earnings, but did not change my price target of $175. Coronavirus fears have driven markets to correction territory, creating a buying opportunity for Zoetis. New drug approval for Simparica Trio tablet will have positive effect on stock. Zoetis Inc. (NYSE: ZTS earnings call The company beat earnings expectations, yet again, with their most recent annual report. ZTS reported quarterly earnings of $.92 per share, beating estimates of $.88 per share. ZTS also beat on revenue, generating $1.67 billion for the quarter, beating estimates by roughly 2.12%. The strong performance of ZTS can be seen in their overall outperformance of the S&P 500 and S&P 500 Pharmaceuticals Index. Obtained from the company's most recent 10-K * A more in-depth analysis of their most recent reports have been included in my models below. My Adjusted Models I w
Show less
Read more
Impact Snapshot
Event Time:
ZTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZTS alerts
High impacting Zoetis Inc. Class A news events
Weekly update
A roundup of the hottest topics
ZTS
News
- Vanguard Health Care Fund's Strategic Moves in Q3 2024: A Focus on Zoetis Inc [Yahoo! Finance]Yahoo! Finance
- Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer RoleBusiness Wire
- Cattle & Porcine/Swine Reproductive Diseases Market, 2024-2029 - Industry Revenues to Reach $975.8 Million by 2029 as Demand for Disease Management Intensifies [Yahoo! Finance]Yahoo! Finance
- Is Zoetis Inc. (ZTS) The Best Pet Stock To Invest In According To Analysts? [Yahoo! Finance]Yahoo! Finance
- Zoetis to Participate in Jefferies London Healthcare ConferenceBusiness Wire
ZTS
Earnings
- 11/4/24 - Beat
ZTS
Sec Filings
- 11/14/24 - Form 3
- 11/12/24 - Form 8-K
- 11/4/24 - Form 10-Q
- ZTS's page on the SEC website